Atlas Trials

Can Intermittent Fasting Induce Weight Loss and Improve Gut Health as Compared to Standard Medical Care in Patients With Obesity/High BMI and Crohn's Disease.

Clinical trial NCT05230160 · UNKNOWN

Trial details

NCT number
NCT05230160
Sponsor
University of Calgary
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Crohn Disease
Start date
2022-03-01
Primary completion
2024-12-20
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.